Pemoline is a stimulant drug of the 4-oxazolidinone class. It was first synthesized
in 1913 but its activity was not discovered until the 1930s. Under the names ...
Pemoline was withdrawn from the U.S. market in 2005. Pemoline stimulates the
central nervous system (brain and nerves). The exact way that pemoline work is ...
Dec 8, 2004 ... Because of its association with life threatening hepatic failure, CYLERT (
pemoline) should not ordinarily be considered as first line drug therapy ...
Get information pemoline (Cylert), an ADD drug removed from the US market in
the United States.
Jul 10, 2015 ... The Agency has concluded that the overall risk of liver toxicity from Cylert and
generic pemoline products outweighs the benefits of this drug.
Apr 1, 2015 ... Pemoline belongs to the group of medicines called central nervous system (CNS)
stimulants. It is used to treat children with attention-deficit ...
Pemoline, first synthesized in 1913, is a CNS stimulant of the lesser known
chemical family of oxazolines. The only other widely known member of this family
J Clin Psychopharmacol. 1999 Jun;19(3):257-64. Controlled trial of high doses of
pemoline for adults with attention-deficit/hyperactivity disorder. Wilens TE(1) ...
Mar 24, 2005 ...  Between the 1975 approval and 1996, there were 193 adverse drug reactions
involving the liver ascribed to pemoline reported to the FDA ...
pemoline | C9H8N2O2 | CID 4723 - structure, chemical names, physical and
chemical properties, classification, patents, literature, biological activities, ...